Matches in SemOpenAlex for { <https://semopenalex.org/work/W3201207822> ?p ?o ?g. }
Showing items 1 to 82 of
82
with 100 items per page.
- W3201207822 endingPage "628" @default.
- W3201207822 startingPage "628" @default.
- W3201207822 abstract "Background and aims: Opicapone proved to be effective in the treatment of end-of-dose motor fluctuations in Parkinson's Disease (PD) patients [1,2]. Non-motor symptoms have a substantial impact on health-related quality-of-life and are reported in about 90% of idiopathic PD patients [3]. End-of-dose motor fluctuations and associated sleep disorders are commonly observed in PD patients under treatment with L-dopa/DOPA decarboxylase inhibitors (DDCI). Therefore, there is the expectation that opicapone might improve such symptoms. Methods: Approximately 30 patients (aged 30 years) with idiopathic PD, treated with 3-8 daily oral doses of L-dopa/ DDCI, with 'wearing-off' and experiencing sleep disorders will receive OPC 50mg once-daily during a 6-week evaluationperiod. L-dopa/DDCI daily dose, but not number of intakes, may be adjusted according to subject response in the first 2 weeks, and kept unchanged afterwards (Figure 1). As a pilot study, no formal sample size calculation was performed. Results: The primary endpoint is change from baseline in total score of Parkinson's Disease Sleep Scale (PDSS-2). Secondary endpoints include tolerability, functional motor and non-motor assessments [MDS-NMS, PDQ-8, Fatigue Scale (PFS-16), ON/OFF home diary] and Global Impression of Change (CGI-C, PGI-C). Study sites are in Germany and Portugal. First-patient-in is expected for 2021 and Last-patient-out to late 2021. Timelines might be impacted by COVID-19 pandemic situation. Conclusion: This study will further evaluate the potential impact of OPC 50mg once-daily as adjunctive therapy to L-dopa/DDCI on PD-associated sleep disorders. (Figure Presented)." @default.
- W3201207822 created "2021-09-27" @default.
- W3201207822 creator A5012075571 @default.
- W3201207822 creator A5022630766 @default.
- W3201207822 creator A5030988662 @default.
- W3201207822 creator A5045428922 @default.
- W3201207822 creator A5050910222 @default.
- W3201207822 creator A5071860003 @default.
- W3201207822 date "2021-01-01" @default.
- W3201207822 modified "2023-09-22" @default.
- W3201207822 title "Opicapone OASIS study in Parkinson's: Design of an open-label, single-arm, pilot trial" @default.
- W3201207822 hasPublicationYear "2021" @default.
- W3201207822 type Work @default.
- W3201207822 sameAs 3201207822 @default.
- W3201207822 citedByCount "0" @default.
- W3201207822 crossrefType "journal-article" @default.
- W3201207822 hasAuthorship W3201207822A5012075571 @default.
- W3201207822 hasAuthorship W3201207822A5022630766 @default.
- W3201207822 hasAuthorship W3201207822A5030988662 @default.
- W3201207822 hasAuthorship W3201207822A5045428922 @default.
- W3201207822 hasAuthorship W3201207822A5050910222 @default.
- W3201207822 hasAuthorship W3201207822A5071860003 @default.
- W3201207822 hasConcept C126322002 @default.
- W3201207822 hasConcept C159110408 @default.
- W3201207822 hasConcept C1862650 @default.
- W3201207822 hasConcept C197934379 @default.
- W3201207822 hasConcept C203092338 @default.
- W3201207822 hasConcept C2778261627 @default.
- W3201207822 hasConcept C2778375690 @default.
- W3201207822 hasConcept C2779134260 @default.
- W3201207822 hasConcept C2779734285 @default.
- W3201207822 hasConcept C2779951463 @default.
- W3201207822 hasConcept C2780405171 @default.
- W3201207822 hasConcept C535046627 @default.
- W3201207822 hasConcept C71924100 @default.
- W3201207822 hasConcept C79544238 @default.
- W3201207822 hasConcept C99508421 @default.
- W3201207822 hasConceptScore W3201207822C126322002 @default.
- W3201207822 hasConceptScore W3201207822C159110408 @default.
- W3201207822 hasConceptScore W3201207822C1862650 @default.
- W3201207822 hasConceptScore W3201207822C197934379 @default.
- W3201207822 hasConceptScore W3201207822C203092338 @default.
- W3201207822 hasConceptScore W3201207822C2778261627 @default.
- W3201207822 hasConceptScore W3201207822C2778375690 @default.
- W3201207822 hasConceptScore W3201207822C2779134260 @default.
- W3201207822 hasConceptScore W3201207822C2779734285 @default.
- W3201207822 hasConceptScore W3201207822C2779951463 @default.
- W3201207822 hasConceptScore W3201207822C2780405171 @default.
- W3201207822 hasConceptScore W3201207822C535046627 @default.
- W3201207822 hasConceptScore W3201207822C71924100 @default.
- W3201207822 hasConceptScore W3201207822C79544238 @default.
- W3201207822 hasConceptScore W3201207822C99508421 @default.
- W3201207822 hasLocation W32012078221 @default.
- W3201207822 hasOpenAccess W3201207822 @default.
- W3201207822 hasPrimaryLocation W32012078221 @default.
- W3201207822 hasRelatedWork W122962516 @default.
- W3201207822 hasRelatedWork W1577054006 @default.
- W3201207822 hasRelatedWork W1919842320 @default.
- W3201207822 hasRelatedWork W1948124738 @default.
- W3201207822 hasRelatedWork W1966831812 @default.
- W3201207822 hasRelatedWork W1967024795 @default.
- W3201207822 hasRelatedWork W1968545875 @default.
- W3201207822 hasRelatedWork W2010436565 @default.
- W3201207822 hasRelatedWork W2057007700 @default.
- W3201207822 hasRelatedWork W2072806486 @default.
- W3201207822 hasRelatedWork W2081509710 @default.
- W3201207822 hasRelatedWork W2409051322 @default.
- W3201207822 hasRelatedWork W2789338523 @default.
- W3201207822 hasRelatedWork W2909614014 @default.
- W3201207822 hasRelatedWork W3011915180 @default.
- W3201207822 hasRelatedWork W3018149387 @default.
- W3201207822 hasRelatedWork W3133210729 @default.
- W3201207822 hasRelatedWork W3135312676 @default.
- W3201207822 hasRelatedWork W3178255436 @default.
- W3201207822 hasRelatedWork W2409307610 @default.
- W3201207822 hasVolume "28" @default.
- W3201207822 isParatext "false" @default.
- W3201207822 isRetracted "false" @default.
- W3201207822 magId "3201207822" @default.
- W3201207822 workType "article" @default.